CAR T Cell Therapy in Cancer Forum

Thursday, March 7, 2019

8:25-8:50 AM Overview of Program
Stephen J. Forman, MD

8:30 – 8:50 AM   CAR T Cells – A Personalized Attack on Cancer
Xiuli Wang, PhD 

8:50 – 9:10 AM CAR T Cell Therapy for Acute Myeloid Leukemia (AML)
Lihua Elizabeth Budde, MD, PhD

 9:10 – 9:30 AM CAR T Cell Therapy for Acute Lymphoblastic Leukemia (ALL)
Samer Khaled, MD

10:00 – 10:20 AM CAR T Cell Therapy for Chronic Lymphocytic Leukemia (CLL) & Central Nervous System (CNS) Lymphoma
 Tanya Siddiqi, MD

10:20 – 10:40 AM  CAR T Cell Therapy for Diffuse Large B-Cell Lymphoma
Alex Herrera, MD

10:40 – 11:00 AM  CAR T Cell Therapy Post Autologous Transplant
Leslie Popplewell, MD

11:00 – 11:20 AM CAR T Cell Therapy For Relapsed Myeloma
 Myo Htut, MD 

12:55 – 1:15 PM  CAR T Cell Therapy Related Toxicities
Lihua Elizabeth Budde, MD, PhD

1:15 – 1:35 PM Infectious Complications in Recipients of CAR T Cells: Epidemiology and Prevention
Sanjeet Dadwal, MD

1:35 – 1:55 PM  Diagnosis and Management of Cardiovascular Complications
Faizi A. Jamal, MD

1:55 – 2:15 PM  CAR T Cell Related Neurotoxicity
Neal Prakash, MD, PhD, FAAN

2:15 – 2:35 PM   Current Use of FDA Approved CAR T Cell Products
 Samer Khaled, MD   

3:05 – 3:25 PM Progress and Challenges in CAR T Cell Therapy for Brain Tumors
Christine E. Brown, PhD

3:25 – 3:45 PM  Targeting Brain Metastases from HER2-Positive Breast Cancer with Intraventricularly Administered CAR T Cells
Jana Portnow, MD

3:45 – 4:05 PM CAR T Cell Therapy for Prostate Cancer and Beyond
Saul Priceman, PhD

4:05 – 4:25 PM CAR T Cell Management from a Nursing Perspective
Jennifer Peterson, MSN, RN

4:25 – 4:45 PM  Moving Natural Killer Cell CARs to the Clinic
Michael A. Caligiuri, MD

4:45 – 5:05 PM Future Directions
Stephen J. Forman, MD

AJCC Cancer Staging Form Supplement for CAR T

Download AJCC Cancer Staging Forms by clicking on the link below:

https://cancerstaging.org

City of Hope may find it necessary to substitute faculty with comparable expertise on those rare occasions necessitated by illness, unforeseen scheduling conflicts or extraordinary occurrences.

Physician Track: How the Experts Treat Hematologic Malignancies

Thursday, March 21, 2019

SESSION: LEUKEMIA

8:00 – 8:40 AM Acute Lymphoblastic Leukemia
Vinod A. Pullarkat, MD

8:40 – 9:20 AM Acute Myeloid Leukemia
Guido Marcucci, MD

9:20 – 10:00 AM Chronic Myeloid Leukemia
David S. Snyder, MD

10:00 – 10:40 AM Myelodysplastic Syndrome
Ryotaro Nakamura, MD

10:40 – 11:20 AM  Waldenström’s Macroglobulinemia
Steven T. Rosen, MD

12:20 – 1:00 PM  Acute Promyelocytic Leukemia
Matthew Mei, MD

1:00 – 1:40 PM  BiTE Therapy for Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)
Anthony Stein, MD

1:40 – 2:20 PM Transplant Strategies for Leukemia and Lymphoma
Stephen J. Forman, MD

SESSION: PLASMA CELL DYSCRASIAS

2:40 – 3:20 PM  Multiple Myeloma
Amrita Krishnan, MD

3:20 – 4:00 PM Light Chain Amyloidosis: Treatment and Management
Michael Rosenzweig, MD

4:40 PM  Adjourn for the Day                           

Friday, March 22, 2019

SESSION: LYMPHOPROLIFERATIVE DISORDERS:

8:00 – 8:40 AM T Cell Lymphoma: Treatment and Pitfalls
Jasmine M. Zain, MD

8:40 – 9:20 AM Cutaneous Lymphomas – What is New?
Christiane Querfeld, MD, PhD

9:20 – 10:00 AM Rational Approaches to Primary CNS Lymphoma in 2018
Leslie Popplewell, MD

10:00 – 10:40 AM Enhancing Assessment of Myeloid Disorders by NGS in the Era of Precision Medicine
Michelle Afkhami, MD

11:40 AM – 12:20 PM  Aplastic Anemia
Ryotaro Nakamura, MD

12:20 – 1:00 PM  Updates in Chronic Lymphocytic Leukemia
Tanya Siddiqi, MD

1:00 – 1:40 PM  Hodgkin Lymphoma
Alison Moskowitz, MD

2:00 – 2:40 PM  Mantle Cell Lymphoma
Alex Herrera, MD

2:40 – 3:20 PM Approach to Prevention and Management of Infectious Complications in Hematologic Malignancy Patients
Sanjeet Singh Dadwal, MD, FACP

3:20 PM Adjourn for the Day

Saturday, March 23, 2019

SESSION: SPECIAL TOPICS

8:00 – 8:40 AM Late Effects of Transplants: Lessons Learned and Strategies to Improve the Health of the HCT Survivor
Saro Armenian, DO, MPH

8:40 – 9:20 AM Follicular Lymphoma
Alex Herrera, MD

9:20 – 10:00 AM CAR T Cell Immunotherapy: Promises and Challenges
Elizabeth Budde, MD, PhD

10:00 AM Adjourn for the Day

AJCC Cancer Staging Form Supplement

Download AJCC Cancer Staging Forms by clicking on the link below:

https://cancerstaging.org

Nursing Track: How the Experts Treat Hematologic Malignancies

Thursday, March 21, 2019

8:00 – 8:50 AM The Future of Cancer Care Through Biologic Profiling and Big Data
Thomas Brown, MD, MBA

8:50 – 9:30 AM  FDA New Approved Drugs
Jennifer Peterson, MSN, RN, OCN, BMTCN
Jennifer Shamai, MS, RN, AOCNS, BMTCN

9:50 – 10:30 AM  The Emerging Role of Medical Cannabis and the Oncology Patient
Allison Winacoo, MSN, RN, CPNP, CPHON, BMTCN

10:30 – 11:20 AM  Clinical Trials for Hematologic Malignancies / Associated Nursing Competencies
Jennifer Peterson, MSN, RN, OCN, BMTCN
Tia Wheatley, DNP, RN, AOCNS, BMTCN

12:20 – 1:00 PM  Multiple Myeloma Updates
Amrita Krishnan, MD 

1:00 – 1:40 PM CAR T Cell Therapies: Current State and Future Development
Tanya Siddiqi, MD

1:40 – 2:20 PM Ethics of Cancer Care
David S. Snyder, MD

2:40 – 3:20 PM Acute Leukemias Updates
Vinod A. Pullarkat, MD
Katrina M. Duncan, MSN, NP

3:20 – 4:00 PM Hematopoietic Cell Transplantation: Evolution, Current and Future State
Stephen J. Forman, MD        

4:00 PM Adjourn for the Day                                       

Friday, March 22, 2019

8:00 – 8:45 AM Mindfulness Practice
Erin Kopp, MSN, ACNP-BC 

8:45 – 9:15 AM Skin Cancer After Treatment of Hematologic Malignancies
David Rice, PhD, MSN, RN, NP, NEA-BC  

9:15 – 9:40 AM Focus on Skin: Types of Wounds and Wound Management in Hematologic Malignancies: Part I
Ann Marie Whaley, NP, CWOCN
Nataki Tomt, MA, BSN, CWOCN

9:50 – 10:20 AM  Focus on Skin: What’s New with Cutaneous Lymphomas
Christiane Querfeld, MD, PhD

10:20 – 10:40 AM  Chronic Graft Versus Host Disease
Erin Kopp, MSN, ACNP-BC

11:40 – 12:10 PM Focus on Skin: Types of Wounds and Wound Management in Hematologic Malignancies: Part II
Ann Marie Whaley, NP, CWOCN
Nataki Tomt, MA, BSN, CWOCN

12:10 – 12:50 PM  Use of Diagnostic Imaging and Imaging Informatics in Hematologic Malignancies
Ammar A. Chaudhry, MD

12:50 – 1:40 PM Palliative Care for the Hematology Patient
Thomas W. Leblanc, MD, MA, MHS, FAAHPM

2:00 – 3:20 PM Professional Incivility: A Workplace Cancer in Need of a Cure
Anne Ireland, MSN, RN, AOCN, CENP

3:20 PM Adjourn for the Day       

Saturday, March 23, 2019      

8:00 – 8:40 AM Infection Prevention Strategies with Hematologic Malignancy / HCT Patients and Antimicrobial Stewardship
Sanjeet Singh Dadwal, MD, FACP

8:40 – 9:20 AM Acknowledging, Reducing, and Managing Patient Pain and Suffering
Tia Wheatley, DNP, RN, AOCNS, BMTCN
Jennifer Shamai, MS, RN, AOCNS, BMTCN

9:40 – 10:20 AM
Late Effects of Transplants: Lessons Learned and Strategies to Improve the Health of the HCT Survivor
Saro Armenian, DO, MPH

10:20 – 11:00 AM  The Aging Population: Considerations and Strategies to Maximize Care and Quality Outcomes for the Older Adult
Janine Overcash, PhD, CNP, FAANP, FAAN

11:00 AM Adjourn for the Day